Medicus Pharma Regains Compliance with Nasdaq Minimum Bid Price Requirement
Medicus Pharma received written notice from Nasdaq on October 23, 2026 confirming it regained compliance with the $1.00 minimum bid price requirement under Listing Rule 5550(a)(2). The notice followed ten consecutive business days of closing bid prices at or above $1.00, from October 12 through October 23, 2026, removing the immediate delisting overhang on the Nasdaq Capital Market.
Key figures
- Compliant days
- ten consecutive business days (Oct 12 - Oct 23, 2026)
- Minimum bid price
- $1.00
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.